Our approach to professional learning

Treating diseases has become increasingly complex. A multidisciplinary approach – from science to business – is becoming increasingly important to address these challenges . We offer inspiring blended courses to help guide the next generation of leaders in life sciences through the layered skill set that they will need to make their own. Our mantra is learning by doing and our courses stimulate active participation with a wide variety of teaching methods, such as animations, expert interviews, self-assessment tools, polls and , teaching cases. and (online) discussions.

We aim to provide 3 key professional learning experiences:

1. Interdisciplinary team work with real-world case studies
2. Inspiring ‘What Really Happened’ sessions with experts from the field
3. Sharing expertise with colleagues and key players from industry, academia, and authority

What’s in a name

Dr. Paul Janssen (1926 - 2003), founder of Janssen Pharmaceutical, was a pioneer in the field of biomedical research, as well as a highly successful entrepreneur. With a drive and curiosity that led him to pursue biomedical research, medicine, chemistry, pharmacology, and entrepreneurship, he discovered, developed, and brought to market many new medicinal products which significantly impacted the lives of many patients. At Paul Janssen Futurelab Leiden, Dr. Janssen’s multidisciplinary approach serves as a role model to inspire future generations of entrepreneurial researchers.

On January 30, 2016, Paul Janssen Futurelab Leiden signed an agreement with Baroness Dora Janssen-Arts to use the name for this initiative. We are, and will remain, an independent non-profit organization and have no financial ties with companies. We do collaborate closely with pharmaceutical and life sciences companies, with authorities and other academic institutions, for instance, for the development of teaching cases that are used in the courses and scholarships that are awarded to promising candidates who would otherwise not be able to join the courses.

Our alumni

Our alumni are more than 400 professionals from over 10 countries in Africa, Asia, Europe, Middle East and USA who are working on the development of new medical interventions from industry, in academia, industry, at authorities etc have already participated in our courses. The on-campus has created a lasting experience and a solid network among our alumni and contributors. Will you be part of the Future?

Our contributors

We are fortunate to have many excellent contributors who help to make the online and on-campus courses a success. Below are a few contributors who have shared their expertise for our courses. Visit the contributor's page to see all contributors.

Our team

Building towards an advanced master

We are actively developing new courses and working towards an advanced master's program. This program focuses on the central theme of enhancing the discovery and development of new medical interventions. It will cover key topics such as biomedical and pharmaceutical sciences, non-clinical and clinical product development, market approval processes, the Common Technical Document & Gap-analysis, intellectual property, and more.

The program will offer a blend of online and on-campus courses. Participants can take these courses individually or combine them to earn a recognized master's degree. Each part-time module includes a multi-week online component (with an average workload of 7-9 hours per week) and an on-campus session.

Designed for postgraduate biomedical and pharmaceutical professionals with experience in academia, industry, or regulatory authorities, the courses allow you to balance professional development with your career and personal life. Take the next step in your career with the flexibility and depth offered by this program.

An initiative of Leiden University Medical Center